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Autosomal-Recessive Intellectual Disability with
Cerebellar Atrophy Syndrome Caused by Mutation
of the Manganese and Zinc Transporter Gene SLC39A8
Kym M. Boycott,1,15,* Chandree L. Beaulieu,1,15 Kristin D. Kernohan,1 Ola H. Gebril,2 Aziz Mhanni,3
Albert E. Chudley,3 David Redl,4 Wen Qin,1 Sarah Hampson,1 Se´bastien Ku¨ry,5 Martine Tetreault,6
Erik G. Puffenberger,7 James N. Scott,8 Ste´phane Bezieau,5 Andre´ Reis,9 Steffen Uebe,9
Johannes Schumacher,10 Robert A. Hegele,11 D. Ross McLeod,4 Marina Ga´lvez-Peralta,12,17
Jacek Majewski,6 Vincent T. Ramaekers,13 Care4Rare Canada Consortium, Daniel W. Nebert,12,14
A. Micheil Innes,4,16 Jillian S. Parboosingh,4,16 and Rami Abou Jamra9,16,18,*
Manganese (Mn) and zinc (Zn) are essential divalent cations used by cells as protein cofactors; various human studies and animal models
have demonstrated the importance of Mn and Zn for development. Here we describe an autosomal-recessive disorder in six individuals
from the Hutterite community and in an unrelated Egyptian sibpair; the disorder is characterized by intellectual disability, develop-
mental delay, hypotonia, strabismus, cerebellar atrophy, and variable short stature. Exome sequencing in one affected Hutterite individ-
ual and the Egyptian family identified the same homozygous variant, c.112G>C (p.Gly38Arg), affecting a conserved residue of SLC39A8.
The affected Hutterite and Egyptian individuals did not share an extended common haplotype, suggesting that the mutation arose inde-
pendently. SLC39A8 is a member of the solute carrier gene family known to import Mn, Zn, and other divalent cations across the plasma
membrane. Evaluation of these two metal ions in the affected individuals revealed variably low levels of Mn and Zn in blood and
elevated levels in urine, indicating renal wasting. Our findings identify a human Mn and Zn transporter deficiency syndrome linked
to SLC39A8, providing insight into the roles of Mn and Zn homeostasis in human health and development.It has long been recognized that various divalent cations
are important for human health; however, for many cat-
ions we still lack a comprehensive understanding of the
biochemical roles within cells and the consequences of
deficiency. For manganese (Mn, Mn2þ) and zinc (Zn,
Zn2þ), these cations act as cofactors to modulate the activ-
ity of proteins, such as enzymes and transcription factors.
Studies in various animal models have demonstrated the
importance of Mn and Zn for development, highlighting
a number of dependent biological systems including meta-
bolism, endocrine control, immunological response, brain
development and function, blood clotting, bone and
connective tissue growth, systemic growth, and reproduc-
tion.1–3 Parallels between these models and human devel-
opment remain to be fully elucidated.
In humans, low Mn levels in blood have been docu-
mented in individuals with epilepsy, Mseleni joint disease,
Down syndrome, osteoporosis, and Perthes disease,4
though the role of Mn, if any, in these conditions is un-
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886 The American Journal of Human Genetics 97, 886–893, Decembpathogenesis of sickle cell disease, diabetes mellitus, alco-
holism, and Alzheimer, Parkinson, and chronic kidney dis-
ease.2 Interestingly, there are a number of rare genetic
diseases resulting from abnormal levels of Zn or Mn,
including acrodermatitis enteropathica (SLC39A4
[OMIM: 201100]),5 spondylocheiro dysplastic Ehlers-Dan-
los syndrome (SLC39A13 [OMIM: 612350]),6 transient
neonatal zinc deficiency (SLC30A2 [OMIM: 608118]),7
and a syndrome of hepatic cirrhosis, dystonia, polycy-
themia, and hypermanganesemia (SLC30A10 [OMIM:
613280]).8 Rare genetic diseases resulting from Mn defi-
ciency have not yet been described. Overall, it is clear we
are just beginning to appreciate the biological significance
of these essential cations.
The Hutterite Brethren is an ethno-religious population
of ~40,000 individuals that is divided into three essentially
endogamous groups termed Schmiedeleut, Dariusleut, and
Lehrerleut.9,10 This community is uniquely suited for
genetic studies due to a small founding population,
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Table 1. Clinical Features of Individuals with the SLC39A8 Homozygous Mutation c.112G>C (p.Gly38Arg)
Family Family A Family B Family C Family D Family E Family F
Individual 1 2 3 4 5 6 7 8
Sex F M M F F M F M
Ethnicity Hutterite-D Hutterite-D Hutterite-S Hutterite-S Hutterite-S Hutterite-S Egyptian Egyptian
Current age (years) 18 23 10 6 6 9 9 3
Age at last exam
(years)
13 17 8 5 5 9 8 2
Growth
Birth length 50th–75th 5th–10th 5th–10th <5th <5th ND normala normala
Birth weight 50th 50th 25th–50th <5th <5th 50th–75th normala normala
Birth OFC 90th 50th normala <5th <5th >95th normala normala
Height 3 to 4 SD 3 to 4 SD 3 SD 5th 5th <5th 5th 5th
Weight 4 SD 4 SD 3 SD 10th 10th 25th–50th 25th 5th
OFC 50th 50th 50th 25th–50th 25th–50th 95th 50th 50th
Development
Head Control (years) 2 4 2 2 2 2 no no
Sit (years) 7 with support 3 with support with support with support no no
Walk (years) no no no no assisted no assisted no
Intellectual disability profound profound severe profound profound profound severe severe
Clinical Features
Hypotonia profound profound severe severe severe severe severe severe
Strabismus yes yes yes yes yes no yes yes
Seizures no no no no no yes myoclonic no
Other recurrent infections,
joint hypermobility
recurrent infections,
joint hypermobility
constipation recurrent
infections
recurrent
infections
recurrent infections hyperreflexia hyperreflexia
Imaging
Skeletal osteopenia osteopenia, flat and
broad long bone
epiphyses
normal skeletal
survey at 16 months
ND ND ND ND ND
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888 The American Journal of Human Genetics 97, 886–893, Decembwell-kept genealogical records, and participation in mod-
ern health care.9,11 Six Hutterite individuals were identi-
fied as sharing a syndrome characterized by profound
intellectual disability, developmental delay, hypotonia,
strabismus, and cerebellar atrophy. Additional features
included variable short stature, osteopenia, and recurrent
infections (Table 1). Hypotonia was evident from birth
and is profound; head control was achieved only in early
childhood and one affected individual achieved sitting at
7 years of age. Occipital frontal circumference was always
within the normal range. Intellectual disability was judged
to be severe in all affected individuals; the older individuals
are able to communicate with a few words and signs. MRI
studies demonstrated a small cerebellum with widened
interfoliate sulci and major fissures consistent with mild
to diffuse cerebellar atrophy in a normally sized posterior
fossa (Figure 1). After unremarkable cytogenetic and meta-
bolic investigations, the affected families were enrolled in
the Care4Rare Canada research project based on their
shared phenotype and ancestry. Informed consent was ob-
tained from the parents and study design was approved by
the Institutional Research Ethics boards at the University
of Calgary and the Children’s Hospital of Eastern Ontario.
Two additional children of Egyptian descent, an 8-year-
old girl and her 2-year-old brother, presented with severe
intellectual disability, developmental delay, hypotonia,
and strabismus (Table 1). These individuals were ascer-
tained as part of a large intellectual disability cohort, sepa-
rate from the Hutterite children. In addition, the female
sibling had early-onset generalized myoclonic seizures
that are now well controlled. MRI of the brain showed
diffuse cerebellar atrophy in both siblings that was much
more severe in the older sister. The younger brother also
showed striking cortical atrophy, particularly of the frontal
lobes. All further examinations, including fundus exami-
nation and ultrasound of heart and abdomen, were unre-
markable. Notably, there was a third sibling who passed
away at 7 months of age with profound developmental
delay and failure to thrive. The parents are consanguineous
(first cousins) and healthy. Informed consent was obtained
from the parents and study design approved by the Institu-
tional Research Ethics boards at the University of Erlangen
in Germany and the National Research Center in Cairo.
Given the history of the Hutterite community, we pre-
dicted that this rare disease would be caused by a shared
homozygous ancestral mutation. Identity-by-descentmap-
ping was performed with DNA from individuals 1, 2, and 3
and GeneChip Human Mapping 10 K (Xba 2.0) and 50 K
(Xba 240) arrays (Affymetrix), as described elsewhere.12
This was followed by fine mapping with PCR amplification
of microsatellite markers (True Allele PCR Premix, Applied
Biosystems), which were then resolved on an ABI3130
automated sequencer (Applied Biosystems) and analyzed
with GeneMapper Software (Applied Biosystems). We
identified a single shared 11.7 Mb homozygous region at
4q22–25 and a maximal region of chr4: 94,964,050–
106,621,864 (hg19) (Figure S1A). No genes within thiser 3, 2015
Figure 1. MRI Findings in Individuals
with Mutation in SLC39A8
MRI findings from individual 1 at 6 years of
age (A), individual 2 at 12 years of age (B),
individual 4 at 3 years of age (C), individual
7 at 8 years of age (D), and individual 6 at 9
years of age (E) demonstrate a small cere-
bellum with wide interfoliate sulci and ma-
jor fissures demonstrating diffuse cerebellar
vermian and hemispheric atrophy. The
posterior fossa is normal in size. MRS over
the left basal ganglia in individual 6 (E)
demonstrates an elevated lactate peak.region had previously been linked to a similar phenotype.
To efficiently identify potential causative variant(s), we
performed whole-exome sequencing using DNA from indi-
vidual 2. The SureSelect Human All Exon Kit version 4 (Agi-
lent) was used for target enrichment, and the library was
sequenced with 100 base-pair paired-end reads on a HiSeq
2000 platform (Illumina), as described previously.13,14 Bio-
informatics analysis of exome sequencing data was carried
out as described previously;13,14 average coverage was
1393 and 93% of exons in the 4q22–25 region were
completely covered at>103. After excluding common var-
iants (R1% minor allele frequency represented in the
NHLBI exome variant server, in-house controls [435], or
Exome Aggregation Consortium), a variant in SLC39A8
(GenBank: NM_022154.5; c.112G>C [p.Gly38Arg]) was
identified. This highly conserved residue is located within
a predicted cytoplasmic domain of the SLC39A8 trans-
membrane protein (UniProt) and predicted to be ‘‘prob-
ably damaging’’ by SIFT15 and PolyPhen-2.16 Sanger
sequencing revealed all affected individuals to be homozy-
gous for this variant, parents heterozygous, and healthy
siblings were either heterozygous or carried the normal
sequence (Figure S2). Finally, to determine the prevalence
of this variant in the Hutterite population, we conducted
genotyping in a Hutterite control cohort with a TaqMan
SNP genotyping assay (Life Technologies). The SLC39A8
variant was present in heterozygous state at a low fre-
quency, 1.7% in Lehrerleut (120 controls) and 3.8% in
Dariusleut (92 controls), but was never observed in a ho-
mozygous state. The variant is present in the Exome Aggre-
gation Consortium (ExAC) database as heterozygous in 2
out of 15,930 alleles that are reportedly from European in-
dividuals. It is unclear whether this is a founder mutation
given the Hutterite population’s European roots, or sepa-
rate mutation events.
Similarly, because of consanguinity of the Egyptian par-
ents, a homozygousmutation was expected. Genome-wide
genotyping of the two affected children and of their
mother (since her parents were also consanguineous) using
the HumanCoreExome BeadChips (Illumina) with 240KThe American Journal of Human Genpolymorphic variants followed by
homozygosity mapping using the
web-based application Homozygosity-
Mapper17 revealed six candidate re-gions spanning a total length of 72 Mb (Figure S1B).
DNA of the affected brother was enriched, using the Sure-
Select Human All Exon Kit version 5 (Agilent), and
sequenced using 100-bp paired-end reads on a HiSeq2500
platform (Illumina). Analysis, base calling, and variant
annotation were performed according to standard
methods.18 An average coverage of 1453 was achieved;
95% of the target sequence was covered at least 203, and
96% was covered at least 53. Only variants with coverage
of 53 ormore were analyzed. After excluding common var-
iants (R1% minor allele frequency represented in the
NHLBI exome variant server, in-house controls [728], or
ExAC database), one homozygous variant remained.
We then repeated filtering steps based on different
in silico parameters (conservation, pathogenicity predic-
tion, mutation scoring) and also on combinations of
different parameters (SIFT,15 PhyloP,19 PolyPhen-2,16
LRT,20 MutationTaster,21 MutationAssessor,22 GERP,23
and CADD24), and the same candidate variant remained
that had a predicted pathogenic effect: c.112G>C
(p.Gly38Arg) (GenBank: NM_022154.5) in SLC39A8. The
variant segregated with the disease in the family
(Figure S2). We conclude that the SLC39A8 c.112G>C
(p.Gly38Arg) variant is responsible for the phenotype in
the affected Hutterite and Egyptian individuals.
To investigate whether the c.112G>C (p.Gly38Arg)
mutation homozygous in the affected individuals of Hutter-
ite andEgyptiandescentarose fromasingle event inadistant
common ancestor, we assessed high-quality SNPs in the 4
Mb surrounding the mutation using WES data. This anal-
ysis demonstrated that these affected individuals did not
share an extended common haplotype (Table S1). Given
this finding and the origin and migration pattern of the
Hutterite population,9 it is highly likely that this is a recur-
rent event andnotderived froma single ancestralmutation.
SLC39A8, also known as zinc- and iron-related protein 8
(ZIP8), is a member of the solute carrier gene (SLC) super-
family25,26 and functions to transport Mn, Zn, Cd, and
Fe across the plasma membrane.27,28 Immunoblot analysis
and immunofluorescence with confocal microscopyetics 97, 886–893, December 3, 2015 889
Figure 2. SLC39A8Mutation Causes a Zinc andManganese Defi-
ciency Syndrome
(A) Evolutionary alignment of SLC39A8 amino acid sequence
shows strict conservation of Gly38. Conservation plot was gener-
ated with Alamut software.
(B and C) Western blot (lymphoblasts) (B) and immunofluores-
cence (fibroblasts) (C) analyses demonstrate normal levels and
localization of SLC39A8 in cells derived from individual 2
compared to controls. GAPDH was used as immunoblot loading
control.
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.conducted according to standard protocols on control and
affected individual lymphoblast and fibroblast cells
(derived from individual 2) demonstrated that there was
no overt effect on SLC39A8 protein abundance or localiza-
tion (Figure 2), suggesting that the mutation probably im-
pacts protein function. To further evaluate pathogenicity
of the p.Gly38Arg variant, we measured the divalent cat-
ions of interest in affected individuals (Table 2). Mn and
Zn levels in blood were either low or very low-normal in
all tested individuals, whereas urine levels tended to be
high, indicating renal wasting. Cd is a toxic metal that
can have adverse health effects when inadvertent environ-
mental exposure occurs; Cd levels were measured for two
of the affected individuals but were not detectable (data
not shown). These findings indicate the p.Gly38Arg
SLC39A8 substitution probably impacts both Mn and Zn
transport, resulting in elemental deficiency secondary to
variable poor absorption and loss of these elements
through the kidney and causes an intellectual disability
with cerebellar atrophy syndrome.890 The American Journal of Human Genetics 97, 886–893, December 3, 2015
Notably, there is some variation among the affected indi-
viduals with regard to Mn and Zn levels. Variability in
these levels can be attributed to a number of factors. First,
there might be partial compensation by alternative trans-
porters (>20 Zn transporters29 and ~5 Mn transporters30
have been identified) and this response might differ be-
tween individuals. Of note, SLC39A8 is ubiquitously ex-
pressed, as are a number of the alternate SLC transporters
with potential functional redundancy.31 Interestingly, hu-
man blood Mn levels have been correlated by genome-
wide significance mapping with SNPs in both SLC39A8
and SLC30A10,32 supporting the important role of
SLC39A8 in Mn homeostasis. Finally, it is likely that tran-
sient cycling of elemental levels between low-normal and
severely low might exist as a result of dietary Mn and/or
Zn intake.
Mn and Zn are essential elements that act as cofactors for
a variety of proteins, including enzymes and transcription
factors involved in energy metabolism, endocrine regula-
tion, immune response, nervous system functions, and
reproduction.1,3,29 Given the abundance and centrality of
Mn- and Zn-dependent processes, it is not surprising that
SLC39A8 transporter deficiency causes the severe multi-
systemic developmental disorder reported here. Further-
more, Slc39a8 hypomorphic mice (expressing 15%–50%
of wild-type levels depending on age and tissue) are
observed at expected Mendelian ratios early in develop-
ment, but die between embryonic day (E) 18.5 and 48 hr
postnatally.33 These mice displayed stunted growth and
pale appearance as early as E11.5, and by birth exhibited
small size, poor weight gain, severe anemia, underdevel-
oped eyes, malformed craniums, and hypoplastic hind
limbs and organs. These findings further support the essen-
tiality of proper SLC39A8 function.
There are a number of lines of evidence from humans
and animals that provide support for a link between the
clinical presentation of these children and Mn deficiency.
First, the pathogenic mechanism of a number of human
conditions with features similar to the disease reported
here has been attributed, at least in part, to a single Mn-
dependent enzyme. For example, arginase deficiency
causes an autosomal-recessive condition characterized by
impaired growth and development, intellectual disability,
and ataxia;34 glutamine synthase deficiency causes brain
abnormalities, seizures, delayed development, and hypo-
tonia.35 Second, a study in Mexico City found that dimin-
ished levels of blood Mn in childhood had a negative
impact on neurological development.36 Third, dietary-
induced Mn deficiency has severe developmental conse-
quences in mice, rats, chickens, pigs, and guinea pigs;
although there are some phenotypic differences, all species
display impaired growth, skeletal abnormalities, and ataxic
characteristics.1,37 Finally, excess dietary and/or environ-
mental Mn has been shown to have several neurotoxic
effects in mice and rats,38 highlighting the vulnerability
of the nervous system. Our findings demonstrate that
many of the animal and human phenotypes caused byThe Americanaltered Mn homeostasis are paralleled in individuals with
altered SLC39A8 function.
Current literature contains a number of reports of Zn
deficiency in humans and model organisms with features
akin to our affected individuals. First, spondylocheiro
dysplastic Ehlers-Danlos syndrome is an autosomal-reces-
sive condition caused by mutations in the SLC39A13
zinc transporter.6 Although this disease is clearly distinct
from that presented here, the phenotype includes short
stature, emphasizing a role for Zn in systemic growth. Sec-
ond, a number of mice with genetic mutations in Zn trans-
porters have been generated and characterized; for
example, Zip13-null mice display delayed growth and con-
nective tissue abnormalities and Zip14-null mice are
growth deficient and have impaired skeletogenesis.2,3,29
Finally, studies in Drosophila and zebrafish have shown
defective neuron migration and growth under conditions
of Zn deficiency.2,3,29 Taken together, it is it clear that Zn
is absolutely pivotal for human health; deficiency as a
result of altered function of SLC39A8 undoubtedly con-
tributes to this disorder.
Finally, mutations in SLC39A8 have been identified and
reported in two additional individuals in an accompa-
nying paper in this issue.39 One of these individuals shares
the p.Gly38Arg substitution reported here in conjunction
with a second alteration, p.Ile340Asn, and is more severely
affected. Both of these subjects had an abnormal glycosyl-
ation pattern of serum transferrin and very recent studies
of individuals 2, 4, and 5 in this report show similar, but
less severe, abnormalities,39 identifying additional insight
into the pathogenesis of this disease as well as a useful
biomarker for future therapeutic studies.
In conclusion, we have identified a homozygous recur-
rent mutation in SLC39A8 that causes defective Mn and
Zn transport, intellectual disability, developmental delay,
hypotonia, strabismus, cerebellar atrophy, and variable
short stature. It remains to be seen whether Mn and Zn
supplementation will have a significant clinical impact
for these affected individuals; this will be largely depen-
dent on the residual ability of the mutant SLC39A8 to
transport Mn and Zn, and/or whether alternative trans-
porters are able to compensate. Importantly, our identifica-
tion of this Mendelian form of Mn and Zn transporter
deficiency provides, in addition to the identification of a
rare disease, insights into the role and essentiality of these
divalent cations in human health and development.Supplemental Data
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